Evidence map›Paper›PMID 38938512›Full record

ArticleFrontiers in endocrinology2024

The indicative effects of apolipoproteins on organic erectile dysfunction: bridging Mendelian randomization and case-control study.

Zhexin Zhang, Mo Yan, Yuezheng Li, Yang Pan, Shangren Wang, Mingming Xu, Hang Zhou, Xiaoqiang Liu

Abstract read
In one paragraph

Article in Frontiers in endocrinology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Zhexin Zhang *Department of Urology, Xiangya Hospital, Central South University, Changsha, China.
Mo Yan *Department of Urology, Xiangya Hospital, Central South University, Changsha, China.
Yuezheng LiDepartment of Urology, Tianjin Medical University General Hospital, Tianjin, China.
Yang PanDepartment of Urology, Tianjin Medical University General Hospital, Tianjin, China.
Shangren WangDepartment of Urology, Tianjin Medical University General Hospital, Tianjin, China.
Mingming XuDepartment of Urology, Tianjin Medical University General Hospital, Tianjin, China.
Hang ZhouDepartment of Urology, Tianjin Medical University General Hospital, Tianjin, China.
Xiaoqiang LiuDepartment of Urology, Tianjin Medical University General Hospital, Tianjin, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The existing research on the association between apolipoproteins (Apos) and erectile dysfunction (ED) primarily relies on observational studies and does not distinguish between organic and psychogenic causes when diagnosing ED. It is difficult to believe that Apos play a role in psychogenic ED. To address these issues, our study explored the causal relationship between lipoproteins and ED using Mendelian randomization (MR) analysis and differentiate between organic and psychogenic ED through the use of nocturnal penile tumescence and rigidity (NPTR) monitoring. Multivariate MR analysis revealed significant causal associations between high-density lipoprotein (HDL), Apo A1, and Apo B/A1 with ED (OR and 95% CI were 0.33 (0.14-0.78), 3.58 (1.52-8.43), and 0.30 (0.13-0.66)). we conducted statistical and analytical analyses on the data of 212 patients using multivariate analyses and receiver operating characteristic (ROC) curves. Patients with organic ED had significantly lower levels of HDL, Apo A1 and Apo A1/B, whereas patients with organic ED had considerably higher levels of Apo B and low-density lipoprotein (LDL). The diagnostic value of Apos in predicting the risk of organic ED was evaluated using ROC curves. The results indicated that Apo A1 and Apo A1/B demonstrated good predictive value. HDL, Apo A1, and Apo A1/B have been identified as risk factors for ED in our study. Furthermore, our research highlights the significance of Apo A1 and Apo A1/Apo B in the development of organic ED and suggests their potential use as indicators to assess the risks associated with organic ED.

Indexed as

ApolipoproteinsErectile DysfunctionMendelian Randomization AnalysisAdultApolipoprotein A-ICase-Control StudiesHumansLipoproteins, HDLMaleMiddle AgedApolipoprotein A-IApolipoproteinsLipoproteins, HDLapolipoproteindiagnosiserectile dysfunctionMendelian randomizationthe nocturnal penile tumescence and rigidity test

Identifiers

PMID38938512
PMCPMC11208309

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.